During the last three months, 8 analysts shared their evaluations of RenaissanceRe Holdings RNR, revealing diverse outlooks from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 1 | 4 | 2 | 1 | 0 |
Last 30D | 1 | 0 | 0 | 0 | 0 |
1M Ago | 0 | 0 | 0 | 0 | 0 |
2M Ago | 0 | 2 | 1 | 0 | 0 |
3M Ago | 0 | 2 | 1 | 1 | 0 |
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $295.75, with a high estimate of $426.00 and a low estimate of $234.00. This current average represents a 4.83% decrease from the previous average price target of $310.75.
Interpreting Analyst Ratings: A Closer Look
An in-depth analysis of recent analyst actions unveils how financial experts perceive RenaissanceRe Holdings. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Joshua Shanker | B of A Securities | Lowers | Buy | $426.00 | $437.00 |
Meyer Shields | Keefe, Bruyette & Woods | Lowers | Outperform | $294.00 | $318.00 |
Michael Phillips | Morgan Stanley | Lowers | Equal-Weight | $245.00 | $265.00 |
Elyse Greenspan | Wells Fargo | Lowers | Overweight | $277.00 | $288.00 |
Elyse Greenspan | Wells Fargo | Lowers | Overweight | $288.00 | $301.00 |
Meyer Shields | Keefe, Bruyette & Woods | Raises | Outperform | $318.00 | $310.00 |
Alex Scott | Barclays | Lowers | Underweight | $234.00 | $287.00 |
Jimmy Bhullar | JP Morgan | Raises | Neutral | $284.00 | $280.00 |
Key Insights:
- Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to RenaissanceRe Holdings. This information offers a snapshot of how analysts perceive the current state of the company.
- Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of RenaissanceRe Holdings compared to the broader market.
- Price Targets: Analysts predict movements in price targets, offering estimates for RenaissanceRe Holdings's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.
To gain a panoramic view of RenaissanceRe Holdings's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on RenaissanceRe Holdings analyst ratings.
Delving into RenaissanceRe Holdings's Background
RenaissanceRe Holdings Ltd provides reinsurance and insurance solutions and related services. The company's core products include property, casualty and specialty reinsurance. Revenue is derived from three sources: net premiums earned from the insurance and insurance products sold; net investment income from the investment of capital funds and cash; and other income from the company's joint ventures, advisory services, and other items. The reportable segments of the company are the Property segment which includes catastrophe and other property reinsurance, and the Casualty and Specialty segment which is comprised of casualty and specialty reinsurance. It derives a majority of its revenue from the Casualty and specialty segment.
Understanding the Numbers: RenaissanceRe Holdings's Finances
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Decline in Revenue: Over the 3 months period, RenaissanceRe Holdings faced challenges, resulting in a decline of approximately -29.34% in revenue growth as of 31 December, 2024. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: RenaissanceRe Holdings's net margin excels beyond industry benchmarks, reaching -8.6%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): RenaissanceRe Holdings's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of -1.93%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): RenaissanceRe Holdings's ROA stands out, surpassing industry averages. With an impressive ROA of -0.38%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a below-average debt-to-equity ratio of 0.19, RenaissanceRe Holdings adopts a prudent financial strategy, indicating a balanced approach to debt management.
What Are Analyst Ratings?
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|